Antitumor peptide

Show results for

Unknown (1077)
Proteomics (146)
Genomics (80)
Transcriptomics (57)
Metabolomics (4)
Other (3)
Clinical (1)
Multiomics (1)

Organisms

Homo sapiens (124)
Mus musculus (75)
Drosophila melanogaster (1)
Bos taurus (1)
Rattus rattus (1)
Escherichia coli (1)
cellular organisms (1)
Arabidopsis thaliana (1)
Elysia crispata (1)
Lactobacillus acidophilus DSM 9126 (1)
Rattus norvegicus (1)
Salvia dominica (1)
Taraxacum mongolicum (1)
Trichinella spiralis (1)

Organisms

Mus musculus (36)
Homo sapiens (25)
Micromonospora maris AB-18-032 (1)
Streptomyces tunisiensis (1)
unidentified (1)

Repository

pride (129)
ENA (71)
geo (50)
biostudies-arrayexpress (17)
iProX (8)
MassIVE (6)
MetaboLights (4)
jPOST (3)
EGA (2)

Tissue

Cell culture (45)
Epithelial cell (19)
T cell (13)
B cell (6)
Blood (5)
Liver (5)
Macrophage (4)
Permanent cell line cell (4)
Spleen (4)
Fibroblast (3)
Lung (3)
Melanocyte (3)
Blood plasma (2)
Bone marrow (2)
Breast (2)
Breast cancer cell line (2)
Cell suspension culture (2)
Colon (2)
Cytotoxic T-lymphocyte (2)
HeLa cell (2)
Hepatocyte (2)
JURKAT cell (2)
Malignant cell (2)
Natural killer cell (2)
Pancreas (2)
Primary cell (2)
Stem cell (2)
Blood cell (1)
CCD-18Co cell (1)
HCT-116 cell (1)

Disease

Breast cancer (13)
Colon cancer (11)
Disease free (5)
Malignant neoplasm of ovary (4)
Pancreatic cancer (4)
Skin melanoma (4)
Brain cancer (2)
Colorectal cancer (2)
Fibrosarcoma (2)
Liver cancer (2)
Lung cancer (2)
Melanoma (2)
Prostate adenocarcinoma (2)
Colorectal Neoplasms (1)
Acute leukemia (1)
Anus cancer (1)
Brain glioblastoma multiforme (1)
Cancer (1)
Cardiovascular system disease (1)
Cell type cancer (1)
Cervix carcinoma (1)
Cholangiocarcinoma (1)
Chronic lymphocytic leukemia (1)
Endometrial cancer (1)
Head and neck cancer (1)
Head and neck squamous cell carcinoma (1)
Hepatocellular carcinoma (1)
Influenza (1)
Lung adenocarcinoma (1)
Lung non-squamous non-small cell carcinoma (1)

Technology Type

Mass Spectrometry (129)
Shotgun proteomics (48)
Bottom-up proteomics (33)
Data-dependent acquisition (17)
Affinity purification coupled with mass spectrometry proteomics (16)
Gel-based experiment (10)
Data-independent acquisition (8)
Top-down proteomics (5)
Mass spectrometry assay (3)
DiaPASEF (2)
Proteogenomics (2)
SRM/MRM (2)
SWATH MS (2)
Mass spectrometry (1)
Affinity proteomics (1)
Glycoproteomics (1)
Immunopeptidomics (1)

Instrument Platform

Orbitrap Fusion Lumos (3)
Illumina NovaSeq 6000 (2)
Q Exactive (2)
Liquid Chromatography MS - negative - reverse-phase (2)
Liquid Chromatography MS - positive - reverse-phase (2)
NextSeq 550 (1)
Orbitrap Eclipse (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2026 (49)
2025 (46)
2024 (36)
2022 (17)
2023 (16)
2021 (15)
2020 (7)
2019 (7)
2018 (6)
2017 (6)
2014 (3)
2016 (2)
2013 (2)
2007 (2)
2015 (1)
2012 (1)
2010 (1)

Metabolite Name

Lumichrome (3)
(S)-3-Hydroxybutyric acid (2)
1-Methyladenosine (2)
2,2,6,6-Tetramethyl-4-piperidinol (2)
2-Hydroxycinnamic acid (2)
3'-AMP (2)
Benzothiazole (2)
Bis(2-methoxyethyl) phthalate (2)
Cerulenin (2)
Chavicol (2)
Choline (2)
Cinnamic acid (2)
Creatine (2)
Creatinine (2)
Cyclo(Pro-Leu) (2)
Didanosine (2)
Diphenyl phosphate (2)
Histamine (2)
Hypoxanthine (2)
Indole (2)
L-Ornithine (2)
Leucinic acid (2)
Leucyl-Isoleucine (2)
Lidocaine (2)
Melilotic acid (2)
N-Acetylputrescine (2)
N-Lactoylvaline (2)
N-Undecanoylglycine (2)
N-lactoyl-Tyrosine (2)
Norepinephrine (2)

First Public Date

2026 (20)
2025 (19)
2024 (19)
2021 (4)
2023 (2)
2020 (2)
2018 (2)
2017 (2)
2013 (1)

Study status

Completed (1)

Study type

Transcription profiling by array (14)
RNA-seq of coding RNA (2)
RNA-seq of coding RNA from single cells (1)
Observational (1)

Release Date

2022 (129)
2021 (119)
2025 (114)
2024 (92)
2018 (88)
2023 (87)
2020 (81)
2019 (65)
2017 (50)
2016 (48)
2015 (47)
2014 (37)
2026 (27)
2013 (26)
2010 (19)
2012 (16)
2011 (14)
2008 (9)
2009 (8)
2007 (4)
2006 (4)
2002 (4)
1999 (3)
2003 (2)
2004 (1)

Lab affiliation

Memorial Sloan Kettering Cancer Center (3)
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421 Homburg, Germany (2)
Eppley Institute for Research in Cancer University of Nebraska Medical Center (2)
Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan. (2)
.L. Talrose Institute for Energy Problems of Chemical Physics, N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Leninsky Pr. 38, Bld.2, 119334, Moscow, Russia (1)
Assistant Member, Immunology Department St. Jude Children's Research Hospital Memphis, TN USA (1)
Barts Cancer Institute, Queen Mary University of London (1)
Binzhou Medical University Hospital (1)
Biomedical Research in Cancer Stem Cells Group,Pathology Department, Collserola Building, Lab 205,Vall d'Hebron Research Institute (VHIR, Passeig Vall d'Hebron 119-129,Barcelona 08035, Spain. Tel: +34-93-489-4169 FAX: +34-93-274-6708 (1)
Biomolecular Mass Spectrometry and Proteomics Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences Utrecht University (1)
CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (1)
CIC bioGUNE Proteomics Platform Bizkaia Tech. Park Build 800 Derio 48160 Spain (1)
CNIO (1)
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. (1)
Cancer Biology laboratory, INIBIBB_UNS_CONICET (1)
Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom (1)
Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi,Takatsuki, Osaka 569-8686, Japan (1)
Centro de Investigación Médica Aplicada (CIMA), Clínica Universidad de Navarra (CUN) (1)
Chair Quantitative Proteomics Director Proteome Center Tuebingen Interfaculty Institute for Cell Biology University of Tuebingen Auf der Morgenstelle 15 72076 Tuebingen Germany (1)
Chair, Cancer Biology & Genetics Program, SKI; Chair, Geoffrey Beene Cancer Research Center; Investigator, Howard Hughes Medical Institute; (1)
Chinese Academy of Sciences Shanghai Institute of Materia Medica (1)
Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Madrid, Spain (1)
College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, China (1)
Core Unit Proteomics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany (1)
Core Unit Proteomics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany. (1)
Department of Biochemistry & Biotechnology, University of Thessaly, Biopolis, 41500, Larissa, Greece (1)
Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore, 117543 (1)
Department of Biology, University of Prince Edward Island (1)
Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (1)
Department of Hepatology, Tianjin Second People’s Hospital, Tianjin, China. Tianjin Research Institute of Liver Diseases, Tianjin, China. (1)

Location

France (1)

Previous page
1 / 137
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 137
Next page

Sort by:

Relevance

Page size

Drosophila Sociality Influences Immune Peptide Load and Apoptosis-induced Tumor Suppression independently of the Antitumor Peptide Defensin

PRJEB103801 | ENA

Peptide of Trichinella spiralis infective larval extract that harnesses growth of human hepatoma cells

This project aimed to explore novel anticancer therapeutics from products of parasite since several data related to benefits from the T. spiralis infection have been documented. We validated antitumor activity of T. spiralis infective larval extract and extricate the parasite-derived-antitumor pepti...

ORGANISM(S): Trichinella spiralis

2022-04-13 | PXD032081 | Pride